Richard Carvajal, MD.
Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Richard Carvajal, MD. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:07 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03767439 · Nivolumab With Vismodegib in Patients With Basal Cell Nevus SyndromeColumbia University · withdrawn · Basal Cell Nevus Syndrome · principal investigator
- Ph1NCT02273219 · Trial of AEB071 in Combination With BYL719 in Patients With MelanomaColumbia University · completed · Uveal Melanoma
- Ph2NCT02230306 · Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain MetastasesMelissa Burgess, MD · terminated · Active Melanoma Brain Metastases
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.